0001104659-15-006720.txt : 20150204 0001104659-15-006720.hdr.sgml : 20150204 20150204171729 ACCESSION NUMBER: 0001104659-15-006720 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150202 FILED AS OF DATE: 20150204 DATE AS OF CHANGE: 20150204 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ophthotech Corp. CENTRAL INDEX KEY: 0001410939 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE PENN PLAZA STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10119 BUSINESS PHONE: 212-845-8200 MAIL ADDRESS: STREET 1: ONE PENN PLAZA STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GUYER DAVID R CENTRAL INDEX KEY: 0001277476 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36080 FILM NUMBER: 15576443 MAIL ADDRESS: STREET 1: 3 TIMES SQUARE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 4 1 a4.xml 4 X0306 4 2015-02-02 0 0001410939 Ophthotech Corp. OPHT 0001277476 GUYER DAVID R C/O OPHTHOTECH CORPORATION ONE PENN PLAZA, 19TH FLOOR NEW YORK NY 10119 1 1 0 0 Chief Executive Officer Common Stock 2015-02-02 4 M 0 15018 10.03 A 15018 D Common Stock 2015-02-02 4 S 0 4718 51.59 D 10300 D Common Stock 2015-02-02 4 S 0 1000 52.43 D 9300 D Common Stock 2015-02-02 4 S 0 4400 53.53 D 4900 D Common Stock 2015-02-02 4 S 0 3600 54.31 D 1300 D Common Stock 2015-02-02 4 S 0 1300 55.40 D 0 D Stock Option (Right To Buy) 10.03 2015-02-02 4 M 0 15018 0.00 D 2023-04-25 Common Stock 15018 421814 D The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2013. These shares were disposed of in multiple transactions on February 2, 2015 at actual sales prices ranging from $51.03 to $52.00 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. These shares were disposed of in multiple transactions on February 2, 2015 at actual sales prices ranging from $52.04 to $53.02 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. These shares were disposed of in multiple transactions on February 2, 2015 at actual sales prices ranging from $53.07 to $54.04 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. These shares were disposed of in multiple transactions on February 2, 2015 at actual sales prices ranging from $54.07 to $55.04 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. These shares were disposed of in multiple transactions on February 2, 2015 at actual sales prices ranging from $55.07 to $55.61 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. This option was granted on April 26, 2013 and vests as to 1/48 of the shares underlying such option each month until April 2017. /s/ Justin Vogel, as Attorney-in-Fact for David Guyer 2015-02-04